Supplemental material
Expert Opinion on Drug Discovery
Volume 14, 2019 - Issue 12
Related Research Data
Similarity between Flavonoid Biosynthetic Enzymes and Flavonoid Protein Targets Captured by Three-Dimensional Computing Approach.
Source:
Georg Thieme Verlag KG
Fragment-based drug discovery and x-ray crystallography
Source:
Springer Berlin Heidelberg
Fragment-based drug discovery as alternative strategy to the drug development for neglected diseases.
Source:
Wiley
Natural product-likeness score and its application for prioritization of compound libraries.
Source:
American Chemical Society (ACS)
Concepts and Core Principles of Fragment-Based Drug Design.
Source:
MDPI AG
Binding of quinolizidine alkaloids to nicotinic and muscarinic acetylcholine receptors.
Source:
American Chemical Society (ACS)
Exploring Natural Product Fragments for Drug and Probe Discovery.
Source:
Swiss Chemical Society
Structural Searching of Biosynthetic Enzymes to Predict Protein Targets of Natural Products
Source:
Georg Thieme Verlag KG
Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design.
Source:
HAL CCSD
Expanding the ChemGPS chemical space with natural products.
Source:
American Chemical Society (ACS)
Fragment-Based Screening in Tandem with Phenotypic Screening Provides Novel Antiparasitic Hits
Source:
SAGE Publications
Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study.
Source:
American Chemical Society (ACS)
Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors.
Source:
HAL CCSD
Bioinspiration from Marine Scaffolds
Source:
Wiley-VCH Verlag GmbH & Co. KGaA
Capturing Nature's Diversity
Source:
Public Library of Science (PLoS)
Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and -3.
Source:
Springer Science and Business Media LLC
Yeast synthetic biology platform generates novel chemical structures as scaffolds for drug discovery.
Source:
American Chemical Society (ACS)
Fragment library design, synthesis and expansion: nurturing a synthesis and training platform.
Source:
Elsevier BV
Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus.
Source:
Proceedings of the National Academy of Sciences
Fragment-based screening with natural products for novel anti-parasitic disease drug discovery
Source:
Taylor & Francis
Linking provided by
